EMERSON PERIN to Chronic Disease
This is a "connection" page, showing publications EMERSON PERIN has written about Chronic Disease.
Connection Strength
0.312
-
The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):169-177.
Score: 0.096
-
Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia. J Card Fail. 2011 Jul; 17(7):601-11.
Score: 0.066
-
Cell-based therapy for chronic ischemic heart disease--a clinical perspective. Cardiovasc Ther. 2011 Jun; 29(3):211-7.
Score: 0.064
-
Percutaneous laser revascularization in patients with chronic total occlusions. J Am Coll Cardiol. 2002 Dec 04; 40(11):2062; author reply 2062-3.
Score: 0.037
-
"Wireless" laser recanalization of chronic total coronary occlusions. J Invasive Cardiol. 2001 May; 13(5):401-5.
Score: 0.033
-
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design. Am Heart J. 2010 Aug; 160(2):215-23.
Score: 0.016